|
2016, Volume 32, Number 1, Page(s) 035-039
|
|
DOI: 10.5146/tjpath.2015.01336 |
Salivary Gland Tumors: A 15- year Report from Iran |
Nasim TAGHAVI1, Soudabeh SARGOLZAEI1, Fatemeh MASHHADIABBAS1, Alireza AKBARZADEH2, Parisa KARDOUNI1 |
1Department of Oral Pathology, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, TEHRAN, IRAN 2Department of Basic Sciences, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, TEHRAN, IRAN |
Keywords:
Salivary gland,Tumor, Iran |
Objective: The aim of this study was to document the clinicopathologic characteristic of salivary gland tumors in Tehran, Iran, over a 15-year
period.
Material and Method: A retrospective study was conducted on salivary gland tumors diagnosed at two pathology centers of Shahid Beheshti
University of Medical Sciences from March 2000 to March 2015. Patient age, sex, tumor site and frequency, as well as clinical and radiographic
features and histopathologic diagnosis constituted the main analysis outcome measures.
Results: Of the 45429 biopsies conducted over 15 years, 6065 (13.3%) cases were oral and maxillofacial lesions and 937 (15.4%) of these had
tumoral diagnoses. Of the 937 tumoral cases, 184 (19.6%) were salivary gland tumors and among 184 cases, 65 (35.3%) were benign and
119 (64.7%) were malignant. Pleomorphic adenoma was the most frequently occurring tumor, comprising 32.6% of all tumors, followed by
mucoepidermoid carcinoma (27.1%) and adenoid cystic carcinoma (22.2%). Tumors were frequently reported in minor salivary glands (75%),
particularly in the palate with 89 (48.4%) cases. The peak ages of incidence were the fourth and sixth decades of life. Malignant salivary gland
tumors showed a predilection for females (72.9%), which was statistically significant (P<0.01).
Conclusion: The data presented herein are similar to previously published reports in other countries and other areas of Iran. However, some
differences were observed in our study, such as higher overall frequency, a lower mean age of patients with malignant tumors, and the particular
sites of involvement. These differences can be attributed to racial factors, the pathology centers of sample collection, and the duration of the studies.
|
|
|
|